Resultados de búsqueda - Oyunbileg Magvanjav
- Mostrando 1 - 2 Resultados de 2
-
1
-
2
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention por Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees, Rhonda M. Cooper‐DeHoff, Julio D. Duarte, Deepak Voora, Stephen E. Kimmel, Caitrin W. McDonough, Yan Gong, Chintan V. Dave, Victoria M. Pratt, Tameka D. Alestock, R. David Anderson, Jorge Alsip, Amer Ardati, Brigitta C. Brott, Lawrence M. Brown, Supatat Chumnumwat, Michael Clare‐Salzler, James C. Coons, Joshua C. Denny, Chrisly Dillon, Amanda R. Elsey, Issam S. Hamadeh, Shuko Harada, William B. Hillegass, Lindsay J. Hines, Richard B. Horenstein, Lucius A. Howell, Linda Jo Bone Jeng, Mark D. Kelemen, Yee Ming Lee, Oyunbileg Magvanjav, May E. Montasser, David R. Nelson, Edith A. Nutescu, Devon Nwaba, Ruth E. Pakyz, Kathleen Palmer, Josh F. Peterson, Toni I. Pollin, Alison H. Quinn, Shawn Robinson, Jamie Schub, Todd C. Skaar, D. Max Smith, Vindhya Sriramoju, Petr Starostik, Tomasz Styŝ, James M. Stevenson, Nicholas Varunok, Mark R. Vesely, Dyson T. Wake, Karen E. Weck, Kristin Weitzel, Russell A. Wilke, James H. Willig, Yuqi Zhao, Rolf P. Kreutz, George A. Stouffer, Philip E. Empey, Nita A. Limdi, Alan R. Shuldiner, Almut G. Winterstein, Julie A. Johnson
Publicado 2017Artigo
Herramientas de búsqueda:
Materias Relacionadas
Internal medicine
Medicine
Adverse effect
Biology
Bone remodeling
Calcitriol
Calcium
Cardiology
Clopidogrel
Confidence interval
Context (archaeology)
Conventional PCI
Denosumab
Endocrinology
Giant cell
Giant-cell tumor of bone
Hazard ratio
Myocardial infarction
Osteoporosis
Paleontology
Pathology
Percutaneous coronary intervention
Prasugrel
Ticagrelor